Latest Commercialization News

Norwood Systems has landed a significant five-year contract with Optus to overhaul its voicemail platform, delivering early milestones on schedule and strengthening its financial position. The company is also advancing its global pipeline with Tier-1 telecom operators and deepening strategic partnerships with Microsoft Azure and AWS.

Carbonxt Group advances commissioning of its Kentucky activated carbon plant while securing $2.5 million in fresh capital and reporting strong sales growth and cost savings ahead of FY26.

Pure Resources has entered a strategic alliance with SSH Group to fast-track development of its Reedy Creek Garnet Project, supported by promising metallurgical test results and exploration progress.

Taiton Resources reports exceptional high-purity quartz assay results from its Kingsgate Project in New South Wales, with SiO2 content reaching 99.97%, underpinning plans for further metallurgical testing and exploration.

Latrobe Magnesium Limited is poised to commence operations at its Demonstration Plant by late May 2025, backed by a $6.3 million funding boost and strategic advances in its international and commercial projects.

Superior Resources Limited reports strong progress on its Steam Engine Gold Project, unveiling new gold zones and advancing feasibility studies, while securing government funding for Bottletree drilling and nearing a maiden resource estimate at Cockie Creek.

Volt Group Limited reported a robust 26.8% revenue increase in Q1 FY25, driven by strong performances in its EcoQuip and Wescone divisions, alongside promising advances in its ATEN Waste Heat to Power technology.

Saferoads Holdings reports a modest quarterly profit driven by cost cuts and prepares to settle the sale of its Road Safety Rentals business, aiming to clear debt and refocus on product sales growth.

Mesoblast has commercially launched Ryoncil in the US for pediatric acute GVHD, backed by a strong cash position and advancing multiple cell therapy programs.

Genetic Signatures Ltd reported a robust 71% jump in quarterly sales to $2.9 million, fueled by strong respiratory testing demand in Australia and key US commercial contracts. The company is advancing its automation and instrument customisation strategy to streamline molecular diagnostics offerings.

Hydrix Limited reports improved operating performance in Q3 FY25, buoyed by FDA clearance of its Gyder Surgical Hip Navigation system and a reduced cash operating loss, while managing tight liquidity with shareholder support.

Elixinol Wellness reported a 13.7% year-on-year revenue increase in Q1 FY25, despite a softer quarter compared to record Q4, with ecommerce momentum and strategic initiatives setting the stage for margin recovery and growth in H2.